{"DataElement":{"publicId":"2182861","version":"1","preferredName":"Last Study Agent Date","preferredDefinition":"The last date the participant took study agent.","longName":"LAST_STUDY_AGT_DT","context":"DCP","contextVersion":"1","DataElementConcept":{"publicId":"2179572","version":"2.31","preferredName":"Agent End Date","preferredDefinition":"The date when agent usage ended.","longName":"AGT_END_DT","context":"DCP","contextVersion":"1","ObjectClass":{"publicId":"2223333","version":"1","preferredName":"Agent","preferredDefinition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect. (NCI)","longName":"C1708","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Agent","conceptCode":"C1708","definition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F62B10F2-76A7-2830-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-02","endDate":null,"createdBy":"UMLLOADER","dateCreated":"2005-05-02","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2231605","version":"1","preferredName":"End Date","preferredDefinition":"The point or place at which something terminates in time, space, or extent.:The particular day, month and year an event will happen or has happened.","longName":"C25496:C25164","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"End","conceptCode":"C25496","definition":"The point or place at which something terminates in time, space, or extent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Date","conceptCode":"C25164","definition":"The particular day, month and year an event has happened or will happen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8B9A59E-8D7C-548F-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-04","endDate":null,"createdBy":"UMLLOADER_CADSR","dateCreated":"2005-06-04","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008565","version":"1","preferredName":"Temporal concepts","preferredDefinition":"Time meaning: Like time, date, frequency, occurence,..etc","longName":"TEMPORAL_CONCEPTS","context":"SPOREs","contextVersion":"2.31","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"B7822ECE-3F17-24F5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-02-25","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-02-25","modifiedBy":"SBREXT","dateModified":"2004-02-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CFCBA97B-D1D3-5D7B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2007-03-19","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Change to use caBIG End Date based on two concepts.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018550","version":"1","preferredName":"Date","preferredDefinition":"The date on which an observation was made or an event occurred.","longName":"DT","context":"NCI Standards","contextVersion":"1","type":"Non-enumerated","dataType":"DATE","minLength":null,"maxLength":"8","minValue":null,"maxValue":null,"decimalPlace":null,"format":"MM/DD/YYYY","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008561","version":"1","preferredName":"Occurrences","preferredDefinition":"dates, times, and durations.","longName":"OCURS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B53BD1AB-090B-398B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-01-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2233081","version":"1","preferredName":"Date","preferredDefinition":"a particular day specified as the time something has, or will, happen.","longName":"C25164","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Date","conceptCode":"C25164","definition":"The particular day, month and year an event has happened or will happen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F90B5E56-BB15-0F45-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-09","modifiedBy":"ONEDATA","dateModified":"2005-06-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"B54EF112-5457-674A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-28","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-01-28","modifiedBy":"ZHWENDY","dateModified":"2023-12-12","changeDescription":"8/3/17 tt added Diagnosis CSI. 6/20/17 jk transferred to NCI Standards per confirmation by Brian Campbell as part of Round 5 finalization task, added reg status.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2179692","version":"1","longName":"TYPE OF CATEGORY","context":"DCP","ClassificationSchemeItems":[{"publicId":"2811734","version":"1","longName":"Case Report Forms","context":"DCP"},{"publicId":"2812325","version":"1","longName":"SeriousAdverseEvents","context":"DCP"},{"publicId":"2957372","version":"1","longName":"Case Report Forms Version 3","context":"DCP"}]},{"publicId":"2194255","version":"1","longName":"Type of Condition","context":"DCP","ClassificationSchemeItems":[{"publicId":"2812377","version":"1","longName":"Bladder Cancer","context":"DCP"},{"publicId":"2812388","version":"1","longName":"Oral Leukoplakia","context":"DCP"},{"publicId":"2812415","version":"1","longName":"Sulindac for Breast Cancer","context":"DCP"},{"publicId":"2812399","version":"1","longName":"Polyphenon E for Cervical Ca","context":"DCP"},{"publicId":"2812364","version":"1","longName":"Barretts Esophagus","context":"DCP"},{"publicId":"2812516","version":"1","longName":"Subclinical Neoplastic Lesions","context":"DCP"},{"publicId":"2812502","version":"1","longName":"Unconjugated Isoflavones in Women at High Risk for Breast Cancer","context":"DCP"},{"publicId":"2812194","version":"1","longName":"ALA PDT - Oral Leukoplakia","context":"DCP"},{"publicId":"2812157","version":"1","longName":"Melanoma Pathobiology - Lovastatin","context":"DCP"},{"publicId":"2812155","version":"1","longName":"Sporadic Colorectal Neoplasia - Atrovastatin","context":"DCP"},{"publicId":"2812189","version":"1","longName":"Polyphenon E - Pre-prostatectomy Prostate Cancer","context":"DCP"},{"publicId":"2812188","version":"1","longName":"Se-Methyl-Seleno-L-Cystein (MSC) in Adult Men","context":"DCP"},{"publicId":"2812202","version":"1","longName":"DIM - Prostate Cancer","context":"DCP"},{"publicId":"2812183","version":"1","longName":"Atrovastatin in Women at High Risk for Breast Cancer","context":"DCP"},{"publicId":"2812177","version":"1","longName":"Safety Study of Resiquimod for Atyical Nevi","context":"DCP"},{"publicId":"2812184","version":"1","longName":"Spectral Markers in ASA","context":"DCP"},{"publicId":"2812190","version":"1","longName":"Acolbifene - High Risk for Breast Cancer","context":"DCP"},{"publicId":"2812154","version":"1","longName":"Bronchial Dysplasia - Sulindac","context":"DCP"},{"publicId":"2812182","version":"1","longName":"Tissue Effect of Finasteride - Prostate Cancer","context":"DCP"},{"publicId":"2812197","version":"1","longName":"Phase II Resiquimod - Atypical Nevi","context":"DCP"},{"publicId":"2812174","version":"1","longName":"Polyphenon E - Hormone Receptor-Negative Breast Cancer","context":"DCP"},{"publicId":"2812151","version":"1","longName":"Prostate - Lycopene","context":"DCP"},{"publicId":"2812152","version":"1","longName":"Barretts Esophagus - ASA-Esomeprazole","context":"DCP"},{"publicId":"2812148","version":"1","longName":"SAMe - Hepatitis C cirrhosis","context":"DCP"},{"publicId":"2812102","version":"1","longName":"Budesonide Lung Nodules","context":"DCP"},{"publicId":"2812149","version":"1","longName":"Pancreatic Mucinous Neoplasms","context":"DCP"},{"publicId":"2812277","version":"1","longName":"Aminolevulinic Acid - Barrett's Esophagus","context":"DCP"},{"publicId":"2812258","version":"1","longName":"Drug and Carcinogen Enzymes - Resveratrol","context":"DCP"},{"publicId":"2812876","version":"1","longName":"Bronchial Dysplasia - Myo-Inositol","context":"DCP"},{"publicId":"2812768","version":"1","longName":"PK and Safety - Novel Retinoid (9cUAB30)","context":"DCP"},{"publicId":"2812539","version":"1","longName":"Polyphenon E - Bladder Cancer","context":"DCP"},{"publicId":"2812553","version":"1","longName":"EGF Receptor Signaling in ACF","context":"DCP"},{"publicId":"2812551","version":"1","longName":"9cUAB30","context":"DCP"},{"publicId":"2812836","version":"1","longName":"Imiquimod for Atypical Nevi","context":"DCP"},{"publicId":"2812949","version":"1","longName":"Exp. PK Formulations of SR13668","context":"DCP"},{"publicId":"2842768","version":"1","longName":"Letrozole - Breast Cancer","context":"DCP"},{"publicId":"2812735","version":"1","longName":"3, 3-Diindolylmethane Cervical Intraepithelial","context":"DCP"},{"publicId":"2813002","version":"1","longName":"Sulindac - Increased Risk of Melanoma","context":"DCP"},{"publicId":"2812998","version":"1","longName":"Pioglitazone - Oral Leukoplakia","context":"DCP"},{"publicId":"3528035","version":"1","longName":"Docosahexaenoic Acid","context":"DCP"},{"publicId":"2813064","version":"1","longName":"Erlotinib - Lesions of Lung","context":"DCP"},{"publicId":"2813043","version":"1","longName":"Ursodeoxycholic Acid - Barrett's Patients","context":"DCP"},{"publicId":"2859628","version":"1","longName":"Breast Sulindac DFMO","context":"DCP"},{"publicId":"2812736","version":"1","longName":"Transdermal 4-OHT vs oral TAM DCIS of the Breast","context":"DCP"},{"publicId":"2936518","version":"1","longName":"Polyphenon E in Women w/ Modulation of Arachidonic Acid","context":"DCP"},{"publicId":"2979172","version":"1","longName":"MyoInositol Chemoprevention in Colitis-Assoc. Dysplasia","context":"DCP"},{"publicId":"3110219","version":"1","longName":"MSC and L SeMet in Adult Men","context":"DCP"},{"publicId":"3114163","version":"1","longName":"Cholecalciferol and Genistein","context":"DCP"},{"publicId":"3018781","version":"1","longName":"Metformin Colorectal Cancer","context":"DCP"},{"publicId":"3018782","version":"1","longName":"Resveratrol in Postmenopausal Women","context":"DCP"},{"publicId":"3152820","version":"1","longName":"Pioglitazone - Lung Pre-Surgical NSCLC","context":"DCP"},{"publicId":"3182878","version":"1","longName":"Vitamin D - Bioactivity in the Skin","context":"DCP"},{"publicId":"3182879","version":"1","longName":"Metformin - Pre-Prostatectomy Prostate Cancer","context":"DCP"},{"publicId":"3293737","version":"1","longName":"UAB30 in NMSC","context":"DCP"},{"publicId":"3303133","version":"1","longName":"Pomegranate - Prostate Cancer","context":"DCP"},{"publicId":"3211792","version":"1","longName":"Barrett's Esophagus Chemoprevention Metformin","context":"DCP"}]},{"publicId":"3335728","version":"1","longName":"Protocols","context":"ABTC","ClassificationSchemeItems":[{"publicId":"3335732","version":"1","longName":"ABTC 0904","context":"ABTC"}]},{"publicId":"3896529","version":"1","longName":"Consortia 2012 Studies","context":"DCP","ClassificationSchemeItems":[{"publicId":"4111771","version":"1","longName":"UWI2013-00-01","context":"DCP"},{"publicId":"4915512","version":"1","longName":"UAZ2015-05-02","context":"DCP"},{"publicId":"3896537","version":"1","longName":"UWI2013-01-02","context":"DCP"},{"publicId":"3896538","version":"1","longName":"UAZ2013-01-01","context":"DCP"},{"publicId":"4261112","version":"1","longName":"UAZ2013-02-01","context":"DCP"},{"publicId":"4528053","version":"1","longName":"NWU2014-03-01","context":"DCP"},{"publicId":"4528055","version":"1","longName":"UAZ2014-03-01","context":"DCP"},{"publicId":"4915511","version":"1","longName":"UAZ2015-05-01","context":"DCP"},{"publicId":"5981652","version":"1","longName":"UAZ2017-09-02","context":"DCP"},{"publicId":"5889185","version":"1","longName":"UWI2016-08-01","context":"DCP"},{"publicId":"5280816","version":"1","longName":"UWI2015-05-01","context":"DCP"},{"publicId":"5280817","version":"1","longName":"UWI2016-07-01","context":"DCP"},{"publicId":"5889187","version":"1","longName":"UWI2017-09-01","context":"DCP"}]}],"AlternateNames":[{"name":"ENGLISH","type":"CONTEXT NAME","context":"DCP"},{"name":"CTEP","type":"USED_BY","context":"CTEP"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"ABTC","type":"USED_BY","context":"ABTC"},{"name":"LAST_STUDY_AGT_DT","type":"USED_BY","context":"CITN"},{"name":"DCP","type":"USED_BY","context":"DCP"}],"ReferenceDocuments":[{"name":"DCP CRF Text","type":"Alternate Question Text","description":"Date Last Dose","url":null,"context":"DCP"},{"name":"Date Last Dose","type":"Preferred Question Text","description":"Date Last Dose","url":null,"context":"DCP"},{"name":"DCP Document Text3","type":"Alternate Question Text","description":"Date of Last Dose of Study Agent","url":null,"context":"DCP"},{"name":"DCP Document Text 2","type":"Alternate Question Text","description":"Date Last Study Agent Taken","url":null,"context":"DCP"},{"name":"DCP Text 1","type":"Alternate Question Text","description":"TAC 1:  End Date","url":null,"context":"DCP"},{"name":"DCP-Text-2","type":"Alternate Question Text","description":"Agent End Date","url":null,"context":"DCP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D751C8E1-8479-1B6B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-09","endDate":null,"createdBy":"MAESKEB","dateCreated":"2004-04-09","modifiedBy":"TITARENKOI","dateModified":"2020-06-09","changeDescription":"9/13/18 jk dup Pref Question text corrected.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}